RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB

Kim Jae Hui; Chang Young Suk; Kim Jong Woo; Kim Chul Gu; Lee Dong Won

首页> 外文期刊>Retina >RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB

【24h】

RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB

机译：术后3型新生血管（视网膜血管性增殖）患者的复发

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To evaluate the incidence, timing, and characteristics of recurrence in patients with Type 3 neovascularization who were initially treated with ranibizumab.

机译：目的：评价患有3型新生血管患者复发的发病率，时序和特征，初始用Ranibizumab治疗。

著录项

来源
《Retina》 |2017年第8期|共8页
作者
Kim Jae Hui; Chang Young Suk; Kim Jong Woo; Kim Chul Gu; Lee Dong Won;
展开▼
作者单位

Konyang Univ Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;

Konyang Univ Dept Ophthalmol Coll Med Daejeon South Korea;

Konyang Univ Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;

Konyang Univ Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;

Konyang Univ Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
retinal angiomatous proliferation; Type 3 neovascularization; age-related macular degeneration; choroidal neovascularization; recurrence; ranibizumab; anti-vascular endothelial growth factor;

机译：视网膜血管性增殖;3型新血管形成;年龄相关的黄斑变性;脉络膜新生血管;复发;ranibizumab;抗血管内皮生长因子;

相似文献

外文文献
中文文献
专利

1. RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB [J] . Kim Jae Hui, Chang Young Suk, Kim Jong Woo, Retina . 2017,第8期

机译：术后3型新生血管（视网膜血管性增殖）患者的复发
2. Intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy (PDT), and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation. [J] . Sahu AK, Narayanan R Retina . 2010,第6期

机译：玻璃体内兰尼单抗，玻璃体内兰尼单抗联合光动力疗法（PDT）和玻璃体内曲安西龙联合PDT治疗视网膜血管瘤增生。
3. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. [J] . Rouvas AA, Papakostas TD, Vavvas D, Retina . 2009,第4期

机译：玻璃体腔内雷珠单抗，玻璃体腔内雷珠单抗联合PDT和玻璃体内曲安西龙与PDT联合治疗视网膜血管瘤增生：一项前瞻性研究。
4. Investigating the Impact of the Surface Properties of Intravitreally Injected Carriers on Their Retinal Bio-Distribution In a Single Nanoplatform [C] . HuangX., ChauY. Bioengineering and Translational Medicine Conference . 2018

机译：研究岩土注射载体表面性质对单个纳米纳米载体视网膜生物分布的影响
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages [O] . Young Gun Park, Young-Jung Roh 2015

机译：玻璃体内雷珠单抗单药治疗视网膜血管瘤增生的一年结果：基于疾病分期的比较分析
7. One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages [O] . 2015

机译：玻璃体内雷珠单抗单药治疗视网膜血管瘤增生的一年结果：基于疾病分期的比较分析

RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB

摘要

著录项

相似文献

相关主题

期刊订阅